Muscarinic receptor agonists
US11034704B2 · kind B2 · utility
9Cited by
7References
13Claims
0Family size
Inventors
Key dates
| Filing date | Sep 26, 2019 |
| Grant date | Jun 15, 2021 |
| Priority date | — |
| Expiry date | Sep 26, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to compounds that are agonists of the muscarinic M1 receptor and which are useful in the treatment of muscarinic M1 receptor mediated diseases. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds. Compounds provided are of formula where m, p, q, W, Z, Y, X1, X2, R1, R2, R3 and R4 are as defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.